Evidence map›Paper›PMID 32484958›Full record

ArticleJournal of medical virology2020

Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19.

Anália Carmo, João Pereira-Vaz, Vanda Mota, Alexandra Mendes, Célia Morais, Andreia Coelho da Silva, Elisabete Camilo, Catarina Silva Pinto, Elizabete Cunha, Janet Pereira and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 3 pooled it
2.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 3 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. [Herbal treatment options for post-viral symptoms and long COVID].Wiener medizinische Wochenschrift (1946) · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. A large series of molecular and serological specimens to evaluate mother-to-child SARS-CoV-2 transmission: a prospective study from the Italian Obstetric Surveillance System.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Anália CarmoLaboratory of Molecular Biology/Virology, Clinical Pathology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.ORCID 0000-0002-7704-4736
João Pereira-VazLaboratory of Molecular Biology/Virology, Clinical Pathology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.ORCID 0000-0002-1444-4097
Vanda MotaLaboratory of Molecular Biology/Virology, Clinical Pathology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Alexandra MendesLaboratory of Molecular Biology/Virology, Clinical Pathology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Célia MoraisLaboratory of Molecular Biology/Virology, Clinical Pathology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Andreia Coelho da SilvaLaboratory of Molecular Biology/Virology, Clinical Pathology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Elisabete CamiloLaboratory of Molecular Biology/Virology, Clinical Pathology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Catarina Silva PintoMolecular Hematology Laboratory, Department of Clinical Hematology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Elizabete CunhaMolecular Hematology Laboratory, Department of Clinical Hematology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Janet PereiraMolecular Hematology Laboratory, Department of Clinical Hematology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Margarida CouceloMolecular Hematology Laboratory, Department of Clinical Hematology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Patrícia MartinhoMolecular Hematology Laboratory, Department of Clinical Hematology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Lurdes CorreiaLaboratory of Molecular Biology/Virology, Clinical Pathology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Gilberto MarquesLaboratory of Molecular Biology/Virology, Clinical Pathology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Lucília AraújoLaboratory of Molecular Biology/Virology, Clinical Pathology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Fernando RodriguesLaboratory of Molecular Biology/Virology, Clinical Pathology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Hospitais da Universidade de Coimbra · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with coronavirus disease-2019 may be discharged based on clinical resolution of symptoms, and evidence for viral RNA clearance from the upper respiratory tract. Understanding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral clearance profile is crucial to establish a re-testing plan on discharge and ending isolation of patients. We aimed to evaluate the number of days that a patient needed to achieve undetectable levels of SARS-CoV-2 in upper respiratory tract specimens (nasopharyngeal swab and/or an oropharyngeal swab). The clearance and persistence of viral RNA was evaluated in two groups of positive patients: those who achieved two negative reverse transcription-polymerase chain reaction (RT-PCR) tests and those who kept testing positive. Patients were organized thereafter in two subgroups, mild illness patients discharged home and inpatients who had moderate to severe illness. Results from RT-PCR tests were then correlated with results from the evaluation of the immune response. The study evidenced that most patients tested positive for more than 2 weeks and that persistence of viral RNA is not necessarily associated with severe disease but may result from a weaker immune response instead.

Indexed as

AdultAgedAged, 80 and overChildConvalescenceCOVID-19COVID-19 TestingCross-Sectional StudiesFemaleHumansMaleMiddle AgedNasopharynxOropharynxPatient DischargeRetrospective StudiesRNA, ViralclearanceCOVID-19RT-PCRSARS-CoV-2

Identifiers

PMID32484958
PMCPMC7301002
OpenAlexW3032350507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.